TD Asset Management
BNTX icon

TD Asset Management’s BioNTech BNTX Stock Holding History

TD Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9M Buy
181,815
+22,845
+14% +$2.15M 0.01% 541
2026
Q1 		$14.1M Sell
158,970
-10,208
-6% -$1.05M 0.01% 577
2025
Q4 		$16.1M Buy
169,178
+1,137
+0.7% +$115K 0.01% 551
2025
Q3 		$16.6M Sell
168,041
-5,754
-3% -$615K 0.01% 544
2025
Q2 		$18.5M Buy
173,795
+162,343
+1,418% +$16.4M 0.02% 507
2025
Q1 		$1.02M Sell
11,452
-32,530
-74% -$3.64M ﹤0.01% 1069
2024
Q4 		$5M Sell
43,982
-158
-0.4% -$18K ﹤0.01% 794
2024
Q3 		$5.22M Buy
44,140
+36,550
+482% +$3.36M ﹤0.01% 790
2024
Q2 		$612K Buy
7,590
+435
+6% +$39.8K ﹤0.01% 1243
2024
Q1 		$665K Buy
+7,155
New +$686K ﹤0.01% 1251
2023
Q1 		– Sell
-50,786
Closed -$7.63M – 1434
2022
Q4 		$7.63M Sell
50,786
-32,035
-39% -$4.93M 0.01% 652
2022
Q3 		$11.1M Buy
82,821
+2,185
+3% +$334K 0.01% 556
2022
Q2 		$12M Sell
80,636
-24,223
-23% -$3.7M 0.01% 553
2022
Q1 		$17.9M Buy
104,859
+1,701
+2% +$286K 0.02% 506
2021
Q4 		$26.6M Buy
103,158
+23,758
+30% +$6.51M 0.02% 446
2021
Q3 		$21.7M Sell
79,400
-67,355
-46% -$21.4M 0.02% 454
2021
Q2 		$48.2M Buy
146,755
+25,784
+21% +$4.86M 0.05% 299
2021
Q1 		$13.2M Buy
120,971
+33,106
+38% +$3.52M 0.01% 568
2020
Q4 		$7.16M Buy
87,865
+29,100
+50% +$2.86M 0.01% 695
2020
Q3 		$4.07M Buy
58,765
+42,865
+270% +$3.08M 0.01% 758
2020
Q2 		$1.06M Buy
+15,900
New +$794K ﹤0.01% 1044

Other funds holding BNTX

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GP
GSK plc London $602M AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
DCP
Davern Capital Partners Ny, New York $587M AUM
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TD Asset Management's BNTX Position: Q2 2026 in Review

TD Asset Management increased its BioNTech (BNTX) stake by 14% in Q2 2026, buying an estimated $2.15M and bringing the position to 181,815 shares worth $16.9M. The position accounts for 0.01% of the portfolio, ranked #541.

TD Asset Management first reported a position in BNTX in Q2 2020 and has held it in 21 quarters since. The position peaked at $48.2M in Q2 2021. 202 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • TD Asset Management held 181,815 shares of BioNTech worth $16.9M as of Q2 2026.
  • TD Asset Management bought 22,845 BioNTech shares in Q2 2026, an estimated $2.15M.
  • BioNTech made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #541 holding.
  • TD Asset Management first reported a position in BioNTech in Q2 2020 and has held it in 21 quarters since.
  • TD Asset Management's BioNTech position peaked at $48.2M in Q2 2021.
  • 202 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.